Free Trial

Emergent BioSolutions (EBS) SEC Filings & 10K Form

Emergent BioSolutions logo
$7.74 -0.10 (-1.26%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$7.82 +0.07 (+0.96%)
As of 02/21/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Emergent BioSolutions SEC Filings

DateFilerForm TypeView
01/15/2025
2:45 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
7:13 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
4:12 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
4:44 PM
Emergent BioSolutions (Issuer)
Lowry Simon C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:36 PM
Emergent BioSolutions (Filer)
Form S-1/A
11/21/2024
3:02 PM
Emergent BioSolutions (Issuer)
Lowry Simon C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
3:00 PM
Emergent BioSolutions (Subject)
OAK HILL ADVISORS LP (Filed by)
Form SC 13G
11/12/2024
9:34 AM
Emergent BioSolutions (Subject)
White Marvin L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:12 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:04 PM
Emergent BioSolutions (Issuer)
LINDAHL RICHARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
6:29 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
7:11 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
11:09 AM
BlackRock Inc. (Filed by)
Emergent BioSolutions (Subject)
Form SC 13G/A
09/03/2024
6:47 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
7:26 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:20 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:34 PM
Emergent BioSolutions (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/31/2024
7:56 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
3:30 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
3:33 PM
Emergent BioSolutions (Issuer)
Fox Jennifer Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:33 PM
Emergent BioSolutions (Issuer)
Hartzel William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
3:30 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2024
3:02 PM
Emergent BioSolutions (Issuer)
Williams Paul Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
3:32 PM
Emergent BioSolutions (Subject)
Form SC 13G/A
07/02/2024
7:19 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
6:05 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
12:30 PM
BlackRock Inc. (Filed by)
Emergent BioSolutions (Subject)
Form SC 13G/A
05/31/2024
2:02 PM
Emergent BioSolutions (Issuer)
Zoon Kathryn C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:34 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
8:40 PM
Dayal Sujata Tyagi (Reporting)
Emergent BioSolutions (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:40 PM
Emergent BioSolutions (Issuer)
White Marvin L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:41 PM
DeGolyer Donald W (Reporting)
Emergent BioSolutions (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:41 PM
Emergent BioSolutions (Issuer)
Fowler Neal Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:41 PM
Emergent BioSolutions (Issuer)
Katkin Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:14 PM
Emergent BioSolutions (Issuer)
Richard Ronald (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:14 PM
Emergent BioSolutions (Issuer)
Zoon Kathryn C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:14 PM
Emergent BioSolutions (Issuer)
Harsanyi Zsolt (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
8:14 PM
Emergent BioSolutions (Issuer)
SULLIVAN LOUIS W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2024
4:15 PM
Emergent BioSolutions (Issuer)
Zoon Kathryn C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
3:44 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2024
3:05 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Bill Gates’ is about to mint millionaires (again) with Stargate. (Ad)

This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.
04/30/2024
4:22 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
4:26 PM
Emergent BioSolutions (Filer)
Form DEF 14A
04/11/2024
4:27 PM
Emergent BioSolutions (Filer)
Form DEFA14A
04/11/2024
4:28 PM
Emergent BioSolutions (Filer)
Form ARS
04/09/2024
6:27 PM
Emergent BioSolutions (Issuer)
Hartzel William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
6:27 PM
Emergent BioSolutions (Issuer)
Glessner Coleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:15 PM
Emergent BioSolutions (Issuer)
Hartzel William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:15 PM
Emergent BioSolutions (Issuer)
LINDAHL RICHARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:16 PM
Emergent BioSolutions (Issuer)
Fox Jennifer Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:16 PM
Emergent BioSolutions (Issuer)
Glessner Coleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:16 PM
Emergent BioSolutions (Issuer)
Williams Paul Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:16 PM
Emergent BioSolutions (Issuer)
PAPA JOSEPH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:21 PM
Emergent BioSolutions (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2024
7:31 PM
Emergent BioSolutions (Issuer)
Hartzel William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:15 PM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:42 PM
Emergent BioSolutions (Issuer)
Fox Jennifer Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:42 PM
Emergent BioSolutions (Issuer)
LINDAHL RICHARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:43 PM
Emergent BioSolutions (Issuer)
Williams Paul Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
5:43 PM
Emergent BioSolutions (Issuer)
Glessner Coleen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
9:02 AM
Emergent BioSolutions (Issuer)
PAPA JOSEPH C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2024
7:26 PM
Emergent BioSolutions (Issuer)
LINDAHL RICHARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
7:28 PM
Emergent BioSolutions (Issuer)
Fox Jennifer Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
7:30 PM
Emergent BioSolutions (Issuer)
Emergent BioSolutions (Issuer)
Williams Paul Anthony (Reporting)
Williams Paul Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
6:25 AM
Emergent BioSolutions (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSE:EBS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners